Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl

Marco Berti, Guido Fanelli, Andrea Casati, Andrea Albertin, Sara Palmisano, Francesco Deni, Valeria Perotti, Giorgio Torri

Research output: Contribution to journalArticle

Abstract

Purpose: To compare analgesic efficacy and occurrence of motor block and other side effects during patient supplemented epidural analgesia (PSEA) with either ropivacaine/fentanyl or bupivacaine/fentanyl mixtures. Methods: In a prospective, randomized, double-blind study, 32 ASA 1-111 patients undergoing major abdominal surgery received an epidural catheter at the T8- T10, followed by integrated general epidural anesthesia. Postoperative epidural analgesia was provided using a patient controlled pump with either ropivacaine 0.2%/2 μg·ml-1 fentanyl (group Ropivacaine, n = 16) or bupivacaine 0.125%/2 μg·ml-1 fentanyl (group Bupivacaine, n = 16) [background infusion 4 - 6 ml·hr-1, 1.5 ml Incremental Doses and 20 min lock out]. Verbal pain rating score, number of incremental doses, consumption of epidural analgesic solution and rescue analgesics, sedation (four-point scale), and pulse oximetry were recorded by a blind observer for 48 hr after surgery. Results: No differences in pain relief, motor block, degree of sedation, pulse oximetry and other side effects were observed between the two groups. The number of incremental doses and the volume of analgesic solution infused epidurally were higher in patients receiving the bupivacaine/fentanyl mixture (10 [0 - 52] I.D. and 236 [204 - 340] ml) than in patients receiving the ropivacaine/fentanyl solution (5 [0 - 50] I.D. and 208 [148 - 260] ml) (P=0.03 and P=0.05, respectively). Conclusion: Using a ropivacaine 0.2%/2 μg-ml-1 fentanyl mixture for patient supplemented epidural analgesia after major abdominal surgery provided similar successful pain relief as bupivacaine 0.125%/2 μg·ml-1 fentanyl, but patients receiving bupivacaine/fentanyl requested more supplemental.

Original languageEnglish
Pages (from-to)27-32
Number of pages6
JournalCanadian Journal of Anesthesia
Volume47
Issue number1
Publication statusPublished - 2000

Fingerprint

Epidural Analgesia
Bupivacaine
Fentanyl
Analgesics
Oximetry
Pain
ropivacaine
Epidural Anesthesia
Double-Blind Method
General Anesthesia
Catheters

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Berti, M., Fanelli, G., Casati, A., Albertin, A., Palmisano, S., Deni, F., ... Torri, G. (2000). Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl. Canadian Journal of Anesthesia, 47(1), 27-32.

Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl. / Berti, Marco; Fanelli, Guido; Casati, Andrea; Albertin, Andrea; Palmisano, Sara; Deni, Francesco; Perotti, Valeria; Torri, Giorgio.

In: Canadian Journal of Anesthesia, Vol. 47, No. 1, 2000, p. 27-32.

Research output: Contribution to journalArticle

Berti, M, Fanelli, G, Casati, A, Albertin, A, Palmisano, S, Deni, F, Perotti, V & Torri, G 2000, 'Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl', Canadian Journal of Anesthesia, vol. 47, no. 1, pp. 27-32.
Berti, Marco ; Fanelli, Guido ; Casati, Andrea ; Albertin, Andrea ; Palmisano, Sara ; Deni, Francesco ; Perotti, Valeria ; Torri, Giorgio. / Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl. In: Canadian Journal of Anesthesia. 2000 ; Vol. 47, No. 1. pp. 27-32.
@article{9352f4253d7748729b743e838c9ac59d,
title = "Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl",
abstract = "Purpose: To compare analgesic efficacy and occurrence of motor block and other side effects during patient supplemented epidural analgesia (PSEA) with either ropivacaine/fentanyl or bupivacaine/fentanyl mixtures. Methods: In a prospective, randomized, double-blind study, 32 ASA 1-111 patients undergoing major abdominal surgery received an epidural catheter at the T8- T10, followed by integrated general epidural anesthesia. Postoperative epidural analgesia was provided using a patient controlled pump with either ropivacaine 0.2{\%}/2 μg·ml-1 fentanyl (group Ropivacaine, n = 16) or bupivacaine 0.125{\%}/2 μg·ml-1 fentanyl (group Bupivacaine, n = 16) [background infusion 4 - 6 ml·hr-1, 1.5 ml Incremental Doses and 20 min lock out]. Verbal pain rating score, number of incremental doses, consumption of epidural analgesic solution and rescue analgesics, sedation (four-point scale), and pulse oximetry were recorded by a blind observer for 48 hr after surgery. Results: No differences in pain relief, motor block, degree of sedation, pulse oximetry and other side effects were observed between the two groups. The number of incremental doses and the volume of analgesic solution infused epidurally were higher in patients receiving the bupivacaine/fentanyl mixture (10 [0 - 52] I.D. and 236 [204 - 340] ml) than in patients receiving the ropivacaine/fentanyl solution (5 [0 - 50] I.D. and 208 [148 - 260] ml) (P=0.03 and P=0.05, respectively). Conclusion: Using a ropivacaine 0.2{\%}/2 μg-ml-1 fentanyl mixture for patient supplemented epidural analgesia after major abdominal surgery provided similar successful pain relief as bupivacaine 0.125{\%}/2 μg·ml-1 fentanyl, but patients receiving bupivacaine/fentanyl requested more supplemental.",
author = "Marco Berti and Guido Fanelli and Andrea Casati and Andrea Albertin and Sara Palmisano and Francesco Deni and Valeria Perotti and Giorgio Torri",
year = "2000",
language = "English",
volume = "47",
pages = "27--32",
journal = "Canadian Journal of Anaesthesia",
issn = "0832-610X",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Patient supplemented epidural analgesia after major abdominal surgery with bupivacaine/fentanyl or ropivacaine/fentanyl

AU - Berti, Marco

AU - Fanelli, Guido

AU - Casati, Andrea

AU - Albertin, Andrea

AU - Palmisano, Sara

AU - Deni, Francesco

AU - Perotti, Valeria

AU - Torri, Giorgio

PY - 2000

Y1 - 2000

N2 - Purpose: To compare analgesic efficacy and occurrence of motor block and other side effects during patient supplemented epidural analgesia (PSEA) with either ropivacaine/fentanyl or bupivacaine/fentanyl mixtures. Methods: In a prospective, randomized, double-blind study, 32 ASA 1-111 patients undergoing major abdominal surgery received an epidural catheter at the T8- T10, followed by integrated general epidural anesthesia. Postoperative epidural analgesia was provided using a patient controlled pump with either ropivacaine 0.2%/2 μg·ml-1 fentanyl (group Ropivacaine, n = 16) or bupivacaine 0.125%/2 μg·ml-1 fentanyl (group Bupivacaine, n = 16) [background infusion 4 - 6 ml·hr-1, 1.5 ml Incremental Doses and 20 min lock out]. Verbal pain rating score, number of incremental doses, consumption of epidural analgesic solution and rescue analgesics, sedation (four-point scale), and pulse oximetry were recorded by a blind observer for 48 hr after surgery. Results: No differences in pain relief, motor block, degree of sedation, pulse oximetry and other side effects were observed between the two groups. The number of incremental doses and the volume of analgesic solution infused epidurally were higher in patients receiving the bupivacaine/fentanyl mixture (10 [0 - 52] I.D. and 236 [204 - 340] ml) than in patients receiving the ropivacaine/fentanyl solution (5 [0 - 50] I.D. and 208 [148 - 260] ml) (P=0.03 and P=0.05, respectively). Conclusion: Using a ropivacaine 0.2%/2 μg-ml-1 fentanyl mixture for patient supplemented epidural analgesia after major abdominal surgery provided similar successful pain relief as bupivacaine 0.125%/2 μg·ml-1 fentanyl, but patients receiving bupivacaine/fentanyl requested more supplemental.

AB - Purpose: To compare analgesic efficacy and occurrence of motor block and other side effects during patient supplemented epidural analgesia (PSEA) with either ropivacaine/fentanyl or bupivacaine/fentanyl mixtures. Methods: In a prospective, randomized, double-blind study, 32 ASA 1-111 patients undergoing major abdominal surgery received an epidural catheter at the T8- T10, followed by integrated general epidural anesthesia. Postoperative epidural analgesia was provided using a patient controlled pump with either ropivacaine 0.2%/2 μg·ml-1 fentanyl (group Ropivacaine, n = 16) or bupivacaine 0.125%/2 μg·ml-1 fentanyl (group Bupivacaine, n = 16) [background infusion 4 - 6 ml·hr-1, 1.5 ml Incremental Doses and 20 min lock out]. Verbal pain rating score, number of incremental doses, consumption of epidural analgesic solution and rescue analgesics, sedation (four-point scale), and pulse oximetry were recorded by a blind observer for 48 hr after surgery. Results: No differences in pain relief, motor block, degree of sedation, pulse oximetry and other side effects were observed between the two groups. The number of incremental doses and the volume of analgesic solution infused epidurally were higher in patients receiving the bupivacaine/fentanyl mixture (10 [0 - 52] I.D. and 236 [204 - 340] ml) than in patients receiving the ropivacaine/fentanyl solution (5 [0 - 50] I.D. and 208 [148 - 260] ml) (P=0.03 and P=0.05, respectively). Conclusion: Using a ropivacaine 0.2%/2 μg-ml-1 fentanyl mixture for patient supplemented epidural analgesia after major abdominal surgery provided similar successful pain relief as bupivacaine 0.125%/2 μg·ml-1 fentanyl, but patients receiving bupivacaine/fentanyl requested more supplemental.

UR - http://www.scopus.com/inward/record.url?scp=0034048678&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034048678&partnerID=8YFLogxK

M3 - Article

C2 - 10626714

AN - SCOPUS:0034048678

VL - 47

SP - 27

EP - 32

JO - Canadian Journal of Anaesthesia

JF - Canadian Journal of Anaesthesia

SN - 0832-610X

IS - 1

ER -